Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase N/A

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Xcytrin (motexafin gadolinum) / AbbVie

ACRIN6690, NCT01082224: Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy

Active, not recruiting

N/A

440

iodinated contrast dye, iodinated radiographic dye, motexafin gadolinium, Xcytrin, Eovist-enhanced MRI

American College of Radiology Imaging Network, National Cancer Institute (NCI)

Liver Cancer

12/23

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites